Charles River Laboratories International vs Revvity

Charles River Laboratories International (CRL), health care, and Revvity (RVTY), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Revvity is worth $16.5B on the stock market and Charles River Laboratories International $15.9B: Revvity is valued at 4% more. Charles River Laboratories International trades at 361 times earnings and Revvity at 65.7; operating margins in their latest fiscal years were 0.63% and 12.5%. Over the past year Charles River Laboratories International's share price has moved +106% and Revvity's +60.0%.

Key facts

Charles River Laboratories International market value
$15.9B
Revvity market value
$16.5B
Charles River Laboratories International P/E
361
Revvity P/E
65.7
Charles River Laboratories International revenue
$4BFY to 2025-12-27
Revvity revenue
$2.9BFY to 2025-12-28
Superinvestors holding both
0

Market values as of .

Charles River Laboratories International vs Revvity: every measure side by side
Measure Charles River Laboratories International Revvity
SectorHealth CareHealth Care
Country United States United States
Fiscal year ends2025-12-272025-12-28
Size
Market cap$15.9Blower$16.5Bhigher
Revenue$4Bhigher$2.9Blower
Earnings-$144.3Mlower$241.2Mhigher
Employees18,300higher11,000lower
Total assets$7.1Blower$12.2Bhigher
Valuation
P/E361higher65.7lower
P/S4.0lower5.8higher
P/B4.9higher2.3lower
Dividend yield0.00%lower0.19%higher
Profitability
Operating margin0.63%lower12.5%higher
Balance sheet
Net assets$3.2Blower$7.3Bhigher
Total liabilities$3.9Blower$4.9Bhigher
Total debt$2.1Blower$3.2Bhigher
Cash on hand$213.8Mlower$919.9Mhigher
Price change
Today-1.00%lower-0.71%higher
1 year+106%higher+60.0%lower

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Both (0)

None of the tracked investors.

Charles River Laboratories International only (7)

Revvity only (3)

Percentages are each holding's share of that investor's reported portfolio. Who owns CRL · Who owns RVTY

Further comparisons

Learn

Questions and answers

Which is bigger, Charles River Laboratories International or Revvity?

By market value, Revvity is the larger: $16.5B against $15.9B for Charles River Laboratories International. By revenue in its latest fiscal year, Charles River Laboratories International is the larger: $4B against $2.9B for Revvity.

Which has the higher P/E ratio?

Charles River Laboratories International: 361, against 65.7 for Revvity. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

Which has the higher operating margin?

Revvity: 12.5%, against 0.63% for Charles River Laboratories International. Operating margin is operating income as a share of revenue in the latest fiscal year.

Which has the higher dividend yield?

Revvity: 0.19%, against 0.00% for Charles River Laboratories International. Dividend yield is the last twelve months' dividends as a share of today's share price.

Which has more debt?

Revvity: $3.2B, against $2.1B for Charles River Laboratories International. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

Which superinvestors own both Charles River Laboratories International and Revvity?

None of the tracked superinvestors holds both in their latest 13F filing. 7 hold Charles River Laboratories International and 3 hold Revvity.

Cite this page

Funkfolio, “Charles River Laboratories International vs Revvity”, data as of 18 November 2026. https://funkfolio.com/compare/crl-vs-rvty

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.